Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02342704
Brief Title: Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants (REVEAL)

First Submitted : January 15, 2015
First Submitted that Met QC Criteria : January 15, 2015
First Posted : January 21, 2015 (Estimate)

Results First Submitted : May 17, 2017
Results First Submitted that Met QC Criteria : May 17, 2017
Results First Posted : June 9, 2017

Last Update Submitted that Met QC Criteria : May 17, 2017
Last Update Posted : June 9, 2017